by Katie Davis
Posted in Biopharma, Life Science & Diagnostics
Across the life sciences market, IPOs are more than just fundraising —they are indicators of investor confidence and market potential. After a slowdown in recent years, IPO activity is picking up pace again in 2025, particularly within biotech. In this blog, Katie Davis explores the latest trends.